1 4 d e c e m b e r 2 0 1 7 | V O L 5 5 2 | N A T U r e | 2 0 5 ArTicLe Structures of the calcium-activated, non-selective cation channel TRPM4 TRPM4 is a calcium-activated, phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P 2 ) -modulated, non-selective cation channel that belongs to the family of melastatin-related transient receptor potential (TRPM) channels. Here we present the electron cryo-microscopy structures of the mouse TRPM4 channel with and without ATP. TRPM4 consists of multiple transmembrane and cytosolic domains, which assemble into a three-tiered architecture. The N-terminal nucleotidebinding domain and the C-terminal coiled-coil participate in the tetrameric assembly of the channel; ATP binds at the nucleotide-binding domain and inhibits channel activity. TRPM4 has an exceptionally wide filter but is only permeable to monovalent cations; filter residue Gln973 is essential in defining monovalent selectivity. The S1-S4 domain and the post-S6 TRP domain form the central gating apparatus that probably houses the Ca 2+ -and PtdIns(4,5)P 2 -binding sites. These structures provide an essential starting point for elucidating the complex gating mechanisms of TRPM4 and reveal the molecular architecture of the TRPM family.
Jiangtao Guo 1,2 *, Ji She 1,2 *, Weizhong Zeng 1,2,3 , Qingfeng chen 1,2,3 , Xiao-chen bai 2,4 & Youxing Jiang 1,2,3 TRPM channels comprise the largest subfamily of TRP channels and have diverse functions in various physiological processes 1-3 . TRPM channels share a conserved N-terminal cytosolic region of about 700 amino acid residues with uncharacterized structure and function. In the C-terminal region, TRPM channels contain the TRP domain followed by a coiled-coil domain 1 . Some TRPM channels such as TRPM2, TRPM6 and TRPM7 have functional enzyme domains at the C terminus and are therefore known as 'chanzymes' (channel plus enzyme) 4-6 . Among the eight members of the TRPM subfamily, TRPM4 and TRPM5 share high sequence homology (about 50% identity) and simi lar biophysical properties such as ligand regulation, voltage dependency, ion selectivity and single-channel conductance 7 . Both channels conduct the calcium-activated, non-selective cationic current first recorded in cardiac tissues 8 . Unlike other TRP channels, TRPM4 and TRPM5 are impermeable to divalent cations such as Ca 2+ and Mg 2+ (ref. 7). Whereas TRPM4 is ubiquitously expressed in the pancreas, heart, prostate, renal tubule and many other tissues and organs 9,10 , TRPM5 is mainly detected in taste receptor cells 11 . TRPM4 is regulated by multiple cellular stimuli 3,7,12 (Extended Data Fig. 1 ). Upon Ca 2+ activation, TRPM4 is desensitized to a steady state within a minute at both negative and positive membrane potentials. This TRPM4 desensitization was attributed to the loss of PtdIns(4,5)P 2 in the membrane due to Ca 2+ -activated phospholipase C 13,14 . In the Ca 2+ -desensitized steady state, TRPM4 exhibits voltage-dependent gating with higher channel-open probability at depolarizing membrane potential 10 . While PtdIns(4,5)P 2 alone cannot activate the channel, its presence with Ca 2+ reverses channel desensitization, potentiates Ca 2+ sensitivity, and mitigates voltage dependence of the channel 13, 14 . Cytosolic ATP can modulate TRPM4 activity in a seemingly paradoxical manner-it inhibits TRPM4 current but can also reverse Ca 2+ desensitization 13, 15, 16 .
TRPM4 activation can depolarize the plasma membrane potential and activate voltage-gated sodium or calcium channels 7 . Thus, its function has been implicated in many important physiological processes including the Bayliss effect in cerebral arteries in response to stretch 17, 18 , breath pacemaking in brainstem neurons 19, 20 , the insulin secretion of pancreatic β cells in response to glucose uptake 21 , and the Ca 2+ -dependent immune response in T lymphocytes and dendritic cells 22 . In cardiac cells, several mutations in TRPM4 were found to be associated with human heart conduction dysfunction [23] [24] [25] [26] [27] . Despite its physiological importance, the lack of structural information about TRPM4 as well as other members of the TRPM family hampers our understanding of the complex regulation of TRPM4. In this study, we determined the structures of the mouse TRPM4 channel by singleparticle electron cryo-microscopy (cryo-EM), revealing the unique molecular architecture of the TRPM family. Along with electrophysiological analysis, we also elucidated the structural basis of ATP modulation and ion selectivity of the TRPM4 channel.
Overall structure of TRPM4
Mouse TRPM4 was purified and reconstituted into nanodiscs and its structures in the apo and ATP-bound states were determined by cryo-EM to a resolution of 3.1 and 2.9 Å, respectively, using the gold-standard Fourier shell correlation (FSC) = 0.143 criteria 28 (Extended Data Figs 2-6 and Methods). The cryo-EM density maps are of sufficient quality for model building of major parts of the protein (Extended Data Fig. 5 ). Both structures represent the closed state and are highly similar except for the nucleotide binding region, as will be discussed later. The electron microscopy map for apo TRPM4 is of better quality at the peripheral region, therefore the apo structure will be used in most of the discussion.
The homotetrameric TRPM4 channel has a molecular mass of about 500 kDa with dimensions of 150 × 100 × 100 Å ( Fig. 1a, b ). Each TRPM4 subunit contains multiple cytosolic domains and the overall architecture of the channel tetramer can be divided into three tiers ( Fig. 1b-d ). The bottom tier consists of the N-terminal nucleotidebinding domain (NBD), the ankyrin repeat domain (ARD) and the C-terminal coiled-coil helix, all of which participate in the tetrameric assembly of the channel. The middle tier consists of a linker helical domain (LHD) containing 12 helices (LH1-LH12), and forms the Article reSeArcH scaffold for multiple inter-domain interactions within the subunit. Four LHDs in a channel tetramer encircle a fenestrated open court beneath the cytosolic entrance of the channel. Embedded in lipid, the S1-S6 six transmembrane domain and the TRP domain constitute the top tier of the channel. Like most classical six transmembrane tetrameric cation channels, the S1-S6 transmembrane domain of each subunit is separated into an S1-S4 voltage-sensing domain (VSD) and an S5-S6 pore domain linked by the S4-S5 linker helix. The tetramer assembly is domain-swapped, with the VSD of one subunit interacting with the pore domain from a neighbouring subunit.
N-terminal cytosolic domains
The N-terminal region of TRPM4 contains NBD, ARD and LHD domains. The 400-residue NBD, thought to be the ATP-binding site 16 , is an α /β protein with a central β sheet formed by nine predominantly parallel β strands (β 3-β 11) and its overall architecture partially resembles the Rossmann-fold dinucleotide-binding proteins ( Fig. 2a ). A structural homology search using the Dali server 29 identified an AMP-binding phosphoribohydrolase named lonely guy (LOG) protein 30, 31 that has the highest structural similarity to the NBD of TRPM4 (Extended Data Fig. 7a ). Two ankyrin repeats (AKR) constitute the ARD and form a rigid unit with the NBD via extensive interdomain interactions between the AKR1 helices and the NBD (Fig. 2b ). The ARD also directly interacts with the NBD of the neighbouring subunit, mediating the tetrameric assembly at the bottom tier of TRPM4; the inter-subunit interactions are mainly hydrogen bonds between hydrophilic or charged residues ( Fig. 2b) . Tetramerization of the NBD and ARD generates a wide-open central hole, which is plugged by the C-terminal coiled-coil helices (Fig. 1b) . The middle-tier LHD has a similar structural arrangement to the linker helices of NOMPC, a mechanosensitive Drosophila TRPN channel 32 . The LHD barely contributes to the tetrameric assembly, but it provides the hub for multiple inter-domain interactions within the subunit and probably mediates the coupling between the bottom tier NBD/ARD tetramer assembly and the top tier transmembrane domain (Extended Data Fig. 8 ).
ATP binding and its inhibition of TRPM4
To confirm ATP binding and define its role in TRPM4 activity, we determined the TRPM4 structure in the presence of ATP at 2.9 Å (Methods), allowing us to identify four bound ATP molecules in the channel tetramer, one per subunit (Fig. 2c ). The ATP site is located at the inter-subunit interface between the NBD and ARD (Fig. 2c, d) , distinct from the classical nucleotide-binding site in proteins with the Rossmann-fold (Extended Data Fig. 7a ). The adenine moiety of ATP is positioned in a pocket formed by the loops between β 6 and α 4 and between α 5 and β 8 of the NBD, and surrounded by aromatic residues of His160, Trp214, and Phe228 ( Fig. 2a, c) . The triphosphate group protrudes out into the interface and is surrounded by multiple basic residues (Fig. 2c ). The triphosphate group appears to be more flexible as its density is less well defined. Structural comparison of TRPM4 in the ATP-bound versus the apo state reveals no global conformational change as the two structures superimposed extremely well in most parts of the protein (Extended Data Fig. 7b ). The major conformational change occurs locally near the ATP-binding site ( Fig. 2d ): upon ATP binding, the N-terminal half of the NBD swings away from the ARD of a neighbouring subunit in a rigid body motion, resulting in the disruption of the inter-subunit interactions at the tetrameric assembly interface.
Cytosolic ATP has divergent effects on TRPM4 activity: free ATP but not Mg 2+ -chelated ATP (ATP·Mg) can inhibit the channel 15 , whereas exposing desensitized TRPM4 to ATP·Mg can alleviate desensitization, thereby increasing channel conductance 13,16 . To define the role Curves are least-square fits to a Hill equation (except H160A) with halfmaximum inhibitory concentration (IC 50 ) values of 2.3 ± 0.5, 6.5 ± 0.8 and 14.2 ± 0.7 μ M, and Hill coefficients n of 1.05 ± 0.09, 0.96 ± 0.08 and 1.16 ± 0.07 for wild type, W214A and Y228A, respectively. The IC 50 value of H160A is larger than 160 μ M.
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of ATP binding at the NBD, we mutated the three aromatic residues at the ATP-binding site to alanine, individually. All mutations resulted in reduced ATP inhibition with the His160Ala mutation having the most profound effect ( Fig. 2e and Extended Data Fig. 7c ). The His160Ala mutant, however, exhibits the same recovery from steady state desensitization as the wild-type channel when exposed to ATP·Mg (Extended Data Fig. 7d ), indicating that ATP binding at the NBD has an inhibitory role in TRPM4 activity. Therefore the ATP-bound TRPM4 structure represents an ATP-inhibited closed state. The channel recovery from desensitization was suggested to be caused by ATP·Mg activation of a lipid kinase that restores the membrane PtdIns(4,5)P 2 level 13 . Because the ATP specificity in TRPM4 is mainly defined by the adenine moiety of the nucleotide (Fig. 2c ), ADP and AMP can also bind and inhibit TRPM4 15 . The basic residues surrounding the ATP site probably stabilize the negatively charged triphosphate group and may prevent the binding of ATP·Mg. The aromatic residues important for ATP binding in TRPM4 are not conserved in TRPM5 (Extended Data Fig. 6 ), explaining the lack of ATP inhibition in TRPM5 33 . The ATP inhibition in TRPM4 is also distinct from that in TRPM6/TRPM7 34, 35 . TRPM6/ TRPM7 is inhibited by ATP·Mg, but not free ATP, and the inhibition probably involves the C-terminal kinase domain that is absent in TRPM4.
With a binding site distant from the ion conduction pore, ATP inhibition is the result of an allosteric gating modulation instead of channel blocking, and the strategic location of the ATP site between the NBD and ARD provides a plausible explanation. Upon channel activation, the cytosolic tetrameric assembly probably undergoes a concerted conformational change, which requires the rearrangement of inter-subunit contact at the assembly interface. We suspect that the interfacial ATP binding causes the NBD and ARD to detach at the assembly interface, which in turn prevents the cytosolic tetramer assembly from undergoing any concerted movement associated with channel activation, and thereby inactivates the channel.
Ion conduction pore and selectivity
The TRPM4 ion conduction pore, consisting of the S5, S6 and pore helix (P), adopts the closed conformation ( Fig. 3a, b ). The four porelining S6 inner helices form a bundle crossing at the cytosolic side with a narrow constriction point of 1 Å radius formed by Ile1036, preventing ion passage. TRPM4 has an exceptionally long loop between the filter and S6, which forms an extracellular turret and encircles a deep vestibule at the external entrance of the channel. The inner surface of the vestibule is lined with multiple acidic residues, generating a highly negative surface potential (Fig. 3a, c ).
TRPM4 has a short-but-wide selectivity filter consisting of the sequence 971 Phe-Gly-Gln (Fig. 3d ). The backbone carbonyls of Phe971 and Gly972 along with the Gln973 side chain, line the ion conduction pathway with a minimum atom-to-atom diameter of approximately 7.6 Å between Gly972 carbonyl oxygen atoms, suggesting the passage of hydrated ions during ion conduction. Notably, TRPM4 is monovalent-selective and impermeable to divalent Ca 2+ or Mg 2+ . We suspect that the selectivity of TRPM4 is partly determined by the hydrated ion radius, of which group II divalents are larger than group I monovalents 36 . Gln973 has an essential role in monovalent selectivity of TRPM4 37 ; its side chain forms a hydrogen bond with the backbone carbonyl of Gly972 from the neighbouring subunit and probably stabilizes the filter configuration. Replacing Gln973 with Glu, Asn or Asp all resulted in increased Ca 2+ permeation ( Fig. 3e ). In particular, the Gln973Asp mutant has almost equal permeability between Na + and Ca 2+ (P Na /P Ca ≈ 1.6) ( Fig. 3e and Extended Data Fig. 9 ). Within the filter and central cavity, multiple electron density peaks are clearly visible and modelled as water and Na + , the only cation in the sample (Fig. 3d ). Most of the distances between the ions and the oxygen atoms from protein or water are in the range of 4-5 Å, too far for direct ion chelation. These oxygen ligands probably stabilize the hydrated monovalent cation by acting as the second hydration shell.
S1-S4 domain and post-S6 TRP domain
The S1-S4 domain of TRPM4 consists of four straight helices tightly packed against each other and adopts a structure similar to that of TRPV1 ( Fig. 4 and Extended Data Fig. 10a ). Despite the presence of one arginine (Arg901) on S4, this arginine does not contribute to voltage sensing as replacing it with alanine did not change the voltage dependence of TRPM4 in the desensitized state (Extended Data Fig. 10b ). Furthermore, the S4 helix runs antiparallel to the S5 helix of a neighbouring subunit with extensive hydrophobic interactions and is unlikely to undergo a similar translational movement expected for a voltage-sensing S4 helix [38] [39] [40] (Fig. 4a ). Therefore, S1-S4 is not the voltage sensor of TRPM4 and probably remains static during channel Article reSeArcH gating. Near the intercellular membrane surface, the S1-S4 helices and the TRP domain enclose a solvent-accessible cavity surrounded by a large number of basic and acidic residues (Fig. 4a) .
The post-S6 TRP domain of TRPM4 is longer than the conventionally defined one 2 and consists of two helices, named TRP helix 1 and TRP helix 2 ( Fig. 4 ). TRP helix 1 contains the conserved TRP box and runs immediately after S6 as a curved helix with its apical side coupled to the S4-S5 linker through tight hydrophobic packing (Fig. 4b) . The C-terminal end of the TRP helix 1 is positioned right underneath the S1-S4 domain with Glu1064 and Arg1068 pointing their side chains into the intracellular-facing cavity. Glu1064 was shown to be important for Ca 2+ activation 41 and we suspect the cavity could potentially house the Ca 2+ -binding site. TRP helix 2 and the loop between the two TRP helices are buried in the lower leaflet of the membrane; the loop also participates in the formation of the cavity with S1-S4 by patching the side opening. The TRP helix 2 is not present in TRPV or TRPA channel structures but was observed in NOMPC 32, 42, 43 .
The S1-S4 and TRP domains form a tightly associated entity directly coupled to the intracellular gate of the pore with S1-S4 connected to S5 through the S4-S5 linker, and TRP helix 1 directly linked to the pore-lining S6 helix (Fig. 4a ). They probably serve as the central gating apparatus of the channel. PtdIns(4,5)P 2 probably modulates TRPM4 activity by binding in the S1-S4 domain in a manner similar to that in TRPV1 44 . Although the exact locations for Ca 2+ and PtdIns(4,5)P 2 binding in TRPM4 remain to be identified, we suspect both ligands bind at the S1-S4/TRP gating apparatus and trigger conformational changes that are coupled to the opening of the pore via the S4-S5 linker and/or TRP helix 1.
Stretcher helix and coiled coil
The C-terminal domain of TRPM4 contains the coiled-coil helix and a long preceding stretcher helix so named for its architectural resemblance to the stretcher of an umbrella. In the channel tetramer, four stretcher helices span from the periphery towards the centre and converge on the long four-helix coiled coil that runs vertically through the central hole of the bottom tier tetramer assembly formed by the NBD and ARD (Fig. 5a ). Other than the covalent linkage to the stretcher helices, the coiled coil does not appear to make any specific contact with the surrounding NBD/ARD, allowing it to slide within the central hole. The primary contact between the C-terminal stretcher/coiled-coil helices and the rest of the channel is mediated by the middle-tier LHD, with a mixture of hydrogen bonds and hydrophobic packing between the N terminus of the stretcher helix and the LH7-8 (Fig. 5b) .
The functional role of the TRPM4 C-terminal domain, if any, remains elusive and warrants further study. The previously proposed modulation sites for phosphorylation, PtdIns(4,5)P 2 binding or calmodulin binding at the C-terminal domain do not appear to be accessible based on the structure 14,16 . However, the structural features of the C-terminal domain would imply that the coiled coil is capable of undergoing an up-and-down sliding motion, which, in turn, can induce lateral movement through the stretcher helices and propagate to the channel transmembrane pore through the middle tier LHD (Fig. 5c ). This could potentially be the structural mechanism of TRPM channel modulation at the C terminus and may occur in some TRPM chanzymes whose functional enzyme domains are located immediately after the coiled coil.
Summary
In conclusion, the TRPM4 channel structures provide an initial glimpse of the molecular architecture of the TRPM family. PtdIns(4,5)P 2 and Ca 2+ probably bind at the transmembrane gating apparatus formed by the S1-S4 and TRP domains and activate the channel via conformational change at the S4-S5 linker and/or TRP helix 1 (Fig. 5c ). ATP binding at the NBD disrupts the bottom-tier tetrameric assembly and allosterically inactivates the channel. The C-terminal coiled coil could potentially undergo a piston-like motion and modulate the channel gating via the stretcher helix. Several important questions pertaining to TRPM4 gating remain to be addressed, including the structural mechanisms of Ca 2+ activation, PtdIns(4,5)P 2 potentiation, Ca 2+ desensitization, and voltage-dependence. Our initial structures, however, provide an essential starting point for elucidating the complex gating mechanisms of TRPM4.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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MethODS
No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment. Protein expression, purification, and nanodisc reconstitution. Mouse TRPM4 (GenBank accession number BC096475) containing a C-terminal 10× His tag was cloned into a pEG BacMan vector 45 and heterologously expressed in HEK293F cells (Life Technologies) using the BacMam system (Thermo Fisher Scientific). The baculovirus was generated in Sf9 cells (Life Technologies) following standard protocol and was used to infect HEK293F cells at a ratio of 1:40 (virus:HEK293F, v/v), supplemented with 10 mM sodium butyrate to boost protein expression.
Cells were cultured in suspension at 37 °C for 48 h and harvested by centrifugation at 3,000g. The cell pellet was re-suspended in buffer A (20 mM Tris pH 8.0, 150 mM NaCl) supplemented with a protease inhibitor cocktail (containing 2 μ g ml −1 each of DNase I, 0.5 μ g ml −1 pepstatin, 2 μ g ml −1 leupeptin and 1 μ g ml −1 aprotinin, and 0.1 mM PMSF) and homogenized by sonication on ice. TRPM4 was extracted with 2% (w/v) N-dodecyl-β -d-maltopyranoside (DDM, Anatrace) supplemented with 0.2% (w/v) cholesteryl hemisuccinate (CHS, Sigma Aldrich) by gentle agitation for 2 h on ice. After extraction, the supernatant was collected following a 40-min centrifugation at 48,000g and incubated with Ni-NTA resin (Qiagen) with gentle agitation, supplemented with 30 mM imidazole. After 4 h, the resin was collected on a disposable gravity column (Bio-Rad), washed in buffer B (buffer A + 0.1% DDM + 0.02% CHS) with imidazole at 30 mM and 60 mM for 3 column volumes each. TRPM4 was eluted with 300 mM imidazole, concentrated, and further purified by size exclusion chromatography on a Superose 6 10/300 GL column (GE Heathcare) pre-equilibrated with buffer B.
The protein peak was collected, concentrated to 40 μ M and reconstituted into lipid nanodiscs following published protocol 44 . Briefly, TRPM4, MSP1 46 and lipid (POPC:POPG:POPE = 3:1:1) were mixed at a molar ratio of 1:4:30, and incubated on ice for 30 min. Detergents were removed by adding Bio-Beads SM2 (Bio-Rad) to a concentration of 100 mg ml −1 followed by gentle agitation. The used Bio-Beads were replaced with fresh ones every 4 h two times. After detergent removal, the sample was loaded onto a Superose 6 10/300 GL column pre-equilibrated with buffer A and the elution peak corresponding to the reconstituted TRPM4 was collected for cryo-electron microscopy analysis (Extended Data Fig. 2) . EM data acquisition. The cryo-EM grids were prepared by applying 3 μ l of TRPM4 in nanodiscs (1.8 mg ml −1 ) to a glow-discharged Quantifoil R1.2/1.3 200-mesh copper holey carbon grid (Quantifoil, Micro Tools GmbH, Germany) and blotted for 4 s under 100% humidity at 4 °C before being plunged into liquid ethane using a Mark IV Vitrobot (FEI). Micrographs were acquired on a Titan Krios microscope (FEI) operated at 300 kV with a K2 Summit direct electron detector (Gatan), using a slit width of 20 eV on a GIF-Quantum energy filter. EPU software (FEI) was used for automated data collection following standard FEI procedure. A calibrated magnification of 46,730× was used for imaging, yielding a pixel size of 1.07 Å on images. The defocus range was set from − 1.5 μ m to − 3 μ m. Each micrograph was dose-fractionated to 30 frames under a dose rate of 4 e − pixel −1 s −1 , with a total exposure time of 15 s, resulting in a total dose of about 50 e − Å −2 . The ATP-bound TRPM4 sample was prepared by adding 5 mM Na 2 ·ATP and 2 mM CaCl 2 into the TRPM4 in nanodiscs, resulting in a sample with 3 mM free ATP, 0.1 mM free Ca 2+ , and about 2 mM Ca·ATP (http://maxchelator.stanford.edu). Only free ATP can bind and inhibit TRPM4 as demonstrated in previous functional study as well as this structural study. Despite the presence of 0.1 mM Ca 2+ in the sample, we did not observe bound Ca 2+ in the ATP-bound TRPM4 structure. This could be because of the low apparent affinity of Ca 2+ in the absence of PtdIns(4,5)P 2 , resulting in a low Ca 2+ occupancy at 0.1 mM concentration. Further study is required to capture the Ca 2+ -bound state. Image processing. For the TRPM4 apo form dataset, motion correction was performed using the MotionCorr2 program 47 , and the CTF parameters of the micrographs were estimated using the GCTF program 48 . All other steps of image processing were performed using RELION 2.0 49 . Initially, about 1,000 particles were manually picked from a few micrographs. Class averages representing projections of TRPM4 in different orientations were selected from the 2D classification of the manually picked particles, and used as templates for automated particle picking from the full dataset of 2,876 micrographs. The extracted particles were binned 3 times and subjected to two rounds of 2D classification, and a total of 437,984 particles were finally selected for 3D classification using the initial model generated by RELION as the reference. Four of the 3D classes showed good secondary structural features and their particles were selected, combined and re-extracted into the original pixel size of 1.07 Å. After 3D refinement with C4 symmetry imposed and particle polishing, the resulting 3D reconstructions from 140,259 particles yielded an electron microscopy map with a resolution of 3.1 Å. The C-terminal part of the coiled-coil domain showed poor density, indicating a local structural heterogeneity. Therefore, we performed a focused 3D classification with density subtraction in order to improve the density of the coiled coil domain 50 . In this approach, only the density corresponding to the coiled-coil domain was kept in each particle image by subtracting the density for all other parts including the nanodisc from the original particles. In the subsequent 3D classification on the modified particles, a soft mask was applied around the coiled-coil domain and all the particle orientations were fixed at the value determined in the initial 3D refinement that generated the 3.1 Å map. After this round of classification, one class (11,545 particles) showed a better density in the coiled-coil domain. The corresponding particles before density subtraction from this class were selected and 3D refined, yielding an electron microscopy map of 3.5 Å for the entire channel in which the majority of coiled-coil domain can be modelled. The data for the ATP-bound TRPM4 was processed following the same procedure. Briefly, 564,549 particles were auto-picked from 2,752 micrographs, and after 2D and 3D classification, 196,618 particles were selected for the final 3D reconstruction and refinement, resulting in an ATP-bound TRPM4 structure with an overall resolution of 2.9 Å after particle polishing. The focused 3D classification at the coiled-coil domain was also performed on the ATP bound data. All resolutions were estimated by applying a soft mask around the protein density and the FSC = 0.143 criterion. ResMap 51 was used to calculate the local resolution map. Model building, refinement, and validation. De novo atomic model building was conducted in Coot 52 . Amino acid assignment was achieved based on the clearly defined density for bulky residues (Phe, Trp, Tyr, and Arg). Models were refined against summed maps using phenix.real_space_refine 53 , with secondary structure restraints applied. The model was validated using previously described methods to avoid overfitting 54, 55 . The initial 3.1 Å electron microscopy density map of apo TRPM4 allowed us to construct a model containing residues 12-24, 68-317, 331-386, 396-484, 501-511, 556-712, 765-830, 848-1090, and 1112-1162. The 3.5 Å electron microscopy map, derived from the focused 3D classification at the coiled coil region, further extended the model at the C terminus by 31 residues (from Gly1162 to Ser1193), which were modelled as poly-alanines owing to the poor side-chain density. Therefore, in all structure representations, the C-terminal coiled coil was extended to Ser1193. The final model for the ATP-bound TRPM4 contained residues 12-24, 68-317, 331-484, 501-519, 557-712, 765-830, 848-1090, and 1112-1193. The statistics for the geometries of the models was generated using MolProbity 56 . Pore radii were calculated using the HOLE program 57 . All the figures were prepared in PyMol 58 or Chimera 59 . Electrophysiology. The trpm4 cDNA was cloned into SalI/SacII sites of the pEGFP-N1 vector (Clontech). All single-site mutants were generated using Quikchange Site-Directed Mutagenesis Kit (Agilent) and confirmed by DNA sequencing. 1-2 μ g of the plasmid was transfected into HEK293 cells that were grown as a mono-layer in 35-mm tissue culture dishes (to ~ 70% confluence) using Lipofectamine 2000 (Life Technology). 24-48 h after transfection, cells were dissociated by trypsin treatment and kept in complete serum-containing medium and re-plated onto 35-mm tissue culture dishes and incubated in a tissue culture incubator until recording. Patch-clamp recording in an inside-out configuration was used to measure both single channel and macroscopic currents of TRPM4 or its mutants overexpressed in HEK293 cells. The standard bath solution (cytosolic side) contained (in mM): 145 caesium methanesulfonate (Cs-MS), 5 NaCl, 1 MgCl 2 , 0.3 CaCl 2 , 10 HEPES buffered with Tris, pH 7.4. For calcium free condition, 0.5 mM EGTA was added to the bath solution without CaCl 2 . The pipette solution (extracellular side) contained (in mM): 150 Na-MS, 1 MgCl 2 , 5 CaCl 2 , 10 HEPES buffered with Tris, pH 7.4. The data was acquired using an AxoPatch 200B amplifier (Molecular Devices) and a low-pass analogue filter set to 1 kHz. The current signal was sampled at a rate of 20 kHz using a Digidata 1322A digitizer (Molecular Devices) and further analysed with pClamp 9 software (Molecular Devices). Patch pipettes were pulled from borosilicate glass (Harvard Apparatus) and heat polished to a resistance of 3-5 MΩ. After the patch pipette attached to the cell membrane, a giga seal (> 10 GΩ) was formed by gentle suction. The inside out configuration was formed by pulling the pipette away from the cell and the pipette tip was exposed to air for a short time in some cases. The holding potential was set to 0 mV. The current and voltage relationship (I-V curve) was obtained using voltage pulses ramp from − 100 to + 100 mV over an 800-ms duration. Sample traces for single-channel recording or the I-V curves of macroscopic currents shown in each figure were obtained from recordings on the same patch. The lipid ligands used in this study are phosphatidylinositol-4,5-bisphosphate diC8 (PtdIns(4,5)P 2 diC8, Echelon). All data points shown in Fig. 2e , Extended Data Figs 1e and 10b are mean ± s.e.m. of five measurements from different patches (n = 5 independent biological replicates).
The chelation of ATP with Mg 2+ and Ca 2+ was taken into account in the measurement of cytosolic ATP inhibition of TRPM4. Specific amounts of CaCl 2 , MgCl 2 , and Na 2 ·ATP were prepared according to MAXCHELATOR to achieve the targeted concentrations of free ATP (0.1, 0. 
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Extended Data Figure 5 | Sample EM density maps of TRPM4. a, Sample maps at various regions of apo TRPM4. The maps are low-pass filtered to 3.1 Å and sharpened with a temperature factor of − 120 Å 2 . b, EM density of coiled-coil region in the apo TRPM4 after focused 3D classification. The map is low-pass filtered to 3.5 Å and sharpened with a temperature factor of − 91 Å 2 . c, Electron microscopy density of ATP and its surrounding residues in the ATP-bound TRPM4. The map is low-pass filtered to 2.9 Å and sharpened with a temperature factor of − 91 Å 2 .
Extended Data Figure 9 | The Q973D mutant remains non-selective among monovalent cations similar to the wild-type TRPM4 channel. Shown are sample I-V curves recorded in bi-ionic conditions with 150 mM Na + in the pipette and 150 mM X + (X = Li, Na, K or Cs) in the bath. Currents were recorded when channels reached desensitized steady state after activation with 300 μ M cytosolic (bath) Ca 2+ . All recordings were repeated at least five times using different patches. 
Data exclusions
Describe any data exclusions. 3-D classification yielded multiple 3-D reconstruction maps. Only the particles that give rise to homogeneous density were selected, combined and used in the final reconstruction and refinement. Details were described in the flowcharts of Extended Data Fig. 2&3 .
Replication
Describe whether the experimental findings were reliably reproduced.
All experimental findings were reliably reproduced.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For structure refinement and model validation, all particles were randomly split into two groups, one group was used for refinement and the other for validation. For channel recording, cells with GFP fluorescence (preoteins were GFP-tagged) were randomly selected for recording.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The investigators were blinded to group allocation during data collection and analysis.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
EPU, RELION 2.0, MotionCorr2, GCTF, pClamp 9, Coot, ResMap, PHENIX, MolProbity, HOLE, PyMol, Chimera
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No restrictions on availability of materials.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). c. Report whether the cell lines were tested for mycoplasma contamination.
Cell line was not tested for mycoplasma contamination.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
HEK293 cell line is a well developed system for expressing mammalian membrane proteins. It is also a commonly used system for electrophysiological recording of over-expressed channel proteins.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
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